63: Crizotinib for ALK rearrangement in non small cell lung cancer
S. Merrick, Sunita Ghosh(Tata Memorial Hospital), E. McMunagle, Sarah Hunter(Guy's and St Thomas' NHS Foundation Trust), Michael Neat(Guy's Hospital), Matthew J. Dalby(University of Glasgow), Ana Montes(Guy's and St Thomas' NHS Foundation Trust), Rohit Lal
Cited by 0
Related Papers
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
|The Lancet Oncology|2021|614
Tunable Supramolecular Hydrogels for Selection of Lineage-Guiding Metabolites in Stem Cell Cultures
|Chem|2016|214
The influence of nanotopography on cell behaviour through interactions with the extracellular matrix – A review
|Bioactive Materials|2021|158
Nanotopographical Induction of Osteogenesis through Adhesion, Bone Morphogenic Protein Cosignaling, and Regulation of MicroRNAs
|ACS Nano|2014|150
Designing stem cell niches for differentiation and self-renewal
|Journal of The Royal Society Interface|2018|150